Frank Pitzer, general manager of Roche Diagnostics' factory in Suzhou, Jiangsu province When Frank Pitzer first visited China, in 2000, he could tell the country was developing rapidly by looking at the infrastructure being built. Two years ago, when he officially relocated to the country as general manager of Swiss healthcare giant Roche Diagnostics' new factory in Suzhou, Jiangsu province, development was still the theme, but with tremendous changes due to a new focus on research and development. Pitzer joined in the Suzhou project in October 2013. He flew regularly to China for preparatory work in 2015 and moved to the city in early 2016 to break ground on the project. He said the new position was exciting, because very few people have the privilege to build a factory from scratch. Roche Diagnostics Suzhou, the company's first production base in the Asia-Pacific region, is scheduled to roll out its first products for sale in Asia this year. The investment in the new factory, covering some 48,000 square meters in the 24-year-old China-Singapore Suzhou Industrial Park, was about 450 million Swiss francs ($472 million). When completed, it is expected to employ about 400 local people. In the long-run, production of 102 products for the Asian market, targeting metabolic, cardiovascular and hepatic diseases, among others, will be transferred from Germany to the Suzhou factory. Pitzer has established a five-person R&D team in Suzhou that is likely to expand. The facility is already cooperating with local universities and professors in other parts of the world in the hope of building up Roche's R&D strength in China. We want to make sure that the interests of Chinese patients will be better reflected within the global development framework, Pitzer said. He said he had noticed a significant improvement in the quality of Chinese academic studies and the output of China's universities over the past three years, laying a solid foundation for good R&D work. However, while innovation was happening in China, it was doing so in a spotty, uncoordinated manner, Pitzer said. But things will change given all the investments that China has made in universities and institutions, and in industries such as healthcare and life science. Former science and technology minister Wan Gang said early this year that China's investment in R&D last year rose 14 percent year-on-year to 1.76 trillion yuan ($279 billion) - which was 2.1 percent of the country's GDP. According to World Bank statistics, spending on R&D in the United States in 2015 equaled 2.8 percent of that country's GDP, compared with 2.9 percent in Germany and 3.3 percent in Japan. China should become one of the leading countries in terms of innovation, and grow into a major technology driving force worldwide by 2050, Wan said. While China may have begun focusing on innovation later than some other countries, Pitzer said there is no significant gap between China and those countries in terms of infrastructure and critical thinking. For science practitioners, critical thinking is vital, he said. I do see that among the employees in our facility. They can make their own decisions and apply knowledge when necessary. China is doing everything right. A lot of innovation will come from the country in the future. It won't take long. vinyl wristbandscustom fidgetcheap silicone wristbandsjordan wristbandpersonalized silicone bracelets
The Chinese military has ceased most of its commercial activities, and is on target to end all such activities by the end of the year, according to Xinhua News Agency.By the end of last month, 100,000 out of 106,000 commercial programs undertaken by the People's Liberation Army had ended, marking an achievement in the PLA's decommercialization efforts, Xinhua reported on Wednesday.The report quoted a PLA department in charge of the work as saying that the Central Military Commission pays great attention to the decommercialization efforts, adding that 26 central government departments and nine commission agencies have been working together to push forward the objective.Plans for the remaining commercial activities, which are sophisticated or sensitive, are being made in accordance with related policies, while issues pertaining to legal affairs, employees, assets and debts have been properly handled according to agreed-upon schedules, the department added.It noted that inspectors will be sent to PLA units to examine whether commercial activities have ceased and whether employees have been adequately compensated. Members of the PLA or the public are also welcome to report concerns via a hotline or email, according to the report.The Chinese military started running its own businesses in the mid-1980s to offset a sharp decrease in the defense budget ordered by then-leader Deng Xiaoping.In 1992, the Central Military Commission officially approved commercial activities by the PLA and the People's Armed Police Force.In February 2016, the commission ordered the PLA and the Armed Police Force to eradicate all commercial activities within three years.Last month, the general offices of the Communist Party of China Central Committee, State Council and Central Military Commission jointly published the Guidelines on the Complete Halt of the Military's Commercial Activities, requesting that units of the PLA and the Armed People Force cease all commercial activities by year-end.The document also stipulates that all property, land and reception facilities owned by the military that have been used for commercial purposes will be directly administered and allocated by the Central Military Commission.
